Target intelligence / Profile preview

Magnesium-dependent enzyme, ion channel, and transporter

Molecular classification
Enzyme, Ion channel, Transporter
01

Overview

Magnesium-dependent enzyme, ion channel, and transporter constitute a vast and heterogeneous group of proteins essential for cellular physiology and systemic mineral balance. Magnesium (Mg2+) acts as a critical cofactor for over 300 enzymes, particularly those involved in energy metabolism where it complexes with ATP to form the biologically active Mg-ATP substrate [1, 2]. This group includes vital ion channels such as TRPM6 and TRPM7, which are primary regulators of magnesium entry into cells, and transporters like the SLC41 family that manage magnesium efflux and distribution [3]. Dysregulation of these proteins is implicated in a wide range of pathologies, including hereditary hypomagnesemia, cardiovascular diseases like arrhythmias and hypertension, and metabolic disorders such as type 2 diabetes [4, 5]. Pharmacological management typically involves direct magnesium supplementation using various salts, while certain drug classes like diuretics and proton pump inhibitors are known to interfere with these targets, leading to secondary deficiencies [1, 5]. Understanding the collective function of these proteins is crucial for maintaining neuromuscular stability and metabolic health.

Other names
Magnesium-binding proteinMagnesiotropic proteinMg2+-dependent protein
02

Mechanism of action

Magnesium ions serve as essential cofactors by coordinating with phosphate groups on ATP and other substrates to facilitate enzymatic catalysis; transporters and channels mediate the selective flux of Mg2+ ions across biological membranes to maintain electrochemical gradients and intracellular signaling concentrations [1, 2].

03

Biological functions

Electrolyte homeostasisATP-dependent enzymatic catalysisDNA and RNA synthesisMuscle contraction and relaxationNeuronal excitability
04

Disease associations

HypomagnesemiaPreeclampsia and EclampsiaCardiac arrhythmiaType 2 diabetes mellitusGitelman syndrome
05

Safety considerations

Hypermagnesemia leading to neuromuscular blockadeCardiac conduction delay and asystoleRespiratory depressionDrug-drug interaction via chelation (e.g., with tetracyclines)
06

Interacting drugs

Magnesium sulfate

7 more in the full profile.

07

Biomarkers

Serum magnesium concentration24-hour urinary magnesium excretionFractional excretion of magnesium (FEMg)Intracellular magnesium level (e.g., in erythrocytes)

Beyond the preview

Go deeper on Magnesium-dependent enzyme, ion channel, and transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium-dependent enzyme, ion channel, and transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call